Literature DB >> 669787

Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp.

M D Poole, J D Oliver.   

Abstract

Laboratory animals were challenged subcutaneously, intraperitoneally, and intravenously with the halophilic lactose-positive Vibrio. Intraperitoneal inocula of 10(8) organisms proved to be rapidly lethal in mice, rats, and hamsters. The 50% lethal doese in ICR strain mice was estimatd to be 8 X 10(5) live cells, injected intraperitoneally or subcutaneously. Subtaneous inocula in mice resulted in severe local infections, characterized by gross edema, and for those animals surviving longer than 48 h, tissue necrosis. Intravenous, intraperitoneal, and subcutaneous injections of 10(8) cells in mice resulted in death within 3 to 6 h. These animals rapidly developed Vibrio bacteremia after injections. V. parahaemolyticus, studied for comparative purposes, produced no morbidity or mortality when injected subcutaneously. Injections of live lactose-positive Vibrio into ligated ileal loops in rats and rabbits consistently proved to be lethal with a high-density bacteremia resulting.

Entities:  

Mesh:

Year:  1978        PMID: 669787      PMCID: PMC421561          DOI: 10.1128/iai.20.1.126-129.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A case of true redcell aplastic anaemia successfully treated with riboflavin.

Authors:  H FOY; A KONDI
Journal:  J Pathol Bacteriol       Date:  1953-04

2.  Tissue invasion by unnamed marine vibrios.

Authors:  C R Fernandez; G A Pankey
Journal:  JAMA       Date:  1975-09-15       Impact factor: 56.272

3.  Studies on enteropathogenic activity of Vibrio parahaemolyticus using ligated gut loop model in rabbits.

Authors:  R Sakazaki; K Tamura; A Nakamura; T Kurata; A Goda
Journal:  Jpn J Med Sci Biol       Date:  1974-02

4.  Clinical manifestations of halophilic non-cholera Vibrio infections.

Authors:  S B Thorsteinsson; J N Minuth; D M Musher
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

5.  Vibrio parahaemolyticus: a potential pathogen from marine sources in Britain.

Authors:  G I Barrow; D C Miller
Journal:  Lancet       Date:  1972-02-26       Impact factor: 79.321

6.  Study of genetic relationships among marine species of the genera Beneckea and Photobacterium by means of in vitro DNA/DNA hybridization.

Authors:  J L Reichelt; P Baumann; L Baumann
Journal:  Arch Microbiol       Date:  1976-10-11       Impact factor: 2.552

7.  Epidemiology, enteropathogenicity, and classification of Vi.rio parahaemolyticus.

Authors:  H Zen-Yoji; S Sakai; T Terayama; Y Kudo; T Ito; M Benoki; M Nagasaki
Journal:  J Infect Dis       Date:  1965-12       Impact factor: 5.226

8.  Extractable lipids of gram-negative marine bacteria: phospholipid composition.

Authors:  J D Oliver; R R Colwell
Journal:  J Bacteriol       Date:  1973-06       Impact factor: 3.490

9.  Enteropathogenicity of Vibrio parahaemolyticus in the ligated rabbit ileum.

Authors:  D F Brown; P L Spaulding; R M Twedt
Journal:  Appl Environ Microbiol       Date:  1977-01       Impact factor: 4.792

10.  Taxonomy of marine bacteria: Beneckea parahaemolytica and Beneckea alginolytica.

Authors:  P Baumann; L Baumann; J L Reichelt
Journal:  J Bacteriol       Date:  1973-03       Impact factor: 3.490

View more
  27 in total

1.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Genetic distinctions among clinical and environmental strains of Vibrio vulnificus.

Authors:  Maria Chatzidaki-Livanis; Michael A Hubbard; Katrina Gordon; Valerie J Harwood; Anita C Wright
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

3.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Bioluminescence in a strain of the human pathogenic bacterium Vibrio vulnificus.

Authors:  J D Oliver; D M Roberts; V K White; M A Dry; L M Simpson
Journal:  Appl Environ Microbiol       Date:  1986-11       Impact factor: 4.792

5.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus.

Authors:  J H Bowdre; M D Poole; J D Oliver
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

7.  Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

Authors:  Y C Chuang; W C Ko; S T Wang; J W Liu; C F Kuo; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Phylogenetic analysis of the incidence of lux gene horizontal transfer in Vibrionaceae.

Authors:  Henryk Urbanczyk; Jennifer C Ast; Allison J Kaeding; James D Oliver; Paul V Dunlap
Journal:  J Bacteriol       Date:  2008-03-21       Impact factor: 3.490

9.  Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Use of the polymerase chain reaction in detection of culturable and nonculturable Vibrio vulnificus cells.

Authors:  L A Brauns; M C Hudson; J D Oliver
Journal:  Appl Environ Microbiol       Date:  1991-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.